Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers

青少年吸烟者尼古丁含量极低香烟的评估

基本信息

  • 批准号:
    9560693
  • 负责人:
  • 金额:
    $ 12.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-08 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This K01 award facilitates the attainment of the Candidate's long-term goal of contributing to the science base that will inform future regulatory policy on nicotine content in cigarettes, particularly as this policy affects adolescents. The activities outlined in this application afford the Candidate excellent training in youth smoking, human behavioral pharmacology and advanced statistical methods; and the Candidate proposes applying this knowledge to an innovative research plan focused on evaluating very low nicotine content cigarettes in adolescent smokers. Reducing the nicotine content of cigarettes to a non-addictive level - a strategy made possible by the 2009 passage of the Family Smoking Prevention and Tobacco Control Act (FSPTCA) - could dramatically reduce smoking rates in the US (Benowitz & Henningfield, 1994). The legislation has the potential to impact the pattern of cigarette smoking over the lifetime, making cigarettes less reinforcing for young people, and thus decreasing the number of teen "chippers" who go on to be lifelong smokers (Sofuoglu & LeSage, 2012). However, little is known about the effects of very low nicotine content (VLNC) cigarettes in adolescents. The optimal dose of nicotine for reducing cigarette demand, effects on smoking topography, acceptability of these cigarettes and adolescents' perceptions of the relative risks of these cigarettes are all open questions. While an FDA-mandated reduction in the nicotine content of cigarettes has the potential to dramatically reduce smoking rates in the population, reducing the nicotine content of cigarettes could have unintended negative consequences in adolescents if these smokers engage in compensatory smoking or perceive VLNC cigarettes as being low in harm. Therefore, evaluating the positive and negative consequences of VLNC cigarette use among adolescent smokers is critical for evaluating the viability of this policy. We propose to examine the effects of VLNC cigarettes using two studies, one completed in the laboratory and one in the natural environment. In Study 1, we will compare the effects of cigarettes varying in nicotine content (normal nicotine content, 0.83], reduced nicotine content [0.28, 0.10] and VLNC [0.06] mg yield) on abstinence-induced craving and withdrawal, affect, perceptions of risk, product acceptability and demand for usual-brand cigarettes in adolescent smokers across four laboratory sessions (n=78). In Study 2 we will randomize adolescent daily smokers (n = 90) to either receive VLNC cigarettes or normal-nicotine content (NNC; 0.83 mg) study cigarettes for three weeks. Participants will be instructed to smoke only those cigarettes. We will conduct daily assessments of total cigarette use (both study cigarette and non-compliant use of usual brand cigarettes; these daily data will be monitored closely for evidence of compensatory smoking), craving, and withdrawal, weekly assessments of breath CO levels, cigarette acceptability, risk perceptions of VLNC and NNC cigarettes and demand for usual-brand cigarettes, and pre- vs. post-use measures of nicotine and toxicant exposure (cotinine and NNAL). Overall, the project will help determine how VLNC cigarettes may affect real-world smoking behavior in adolescents, and illuminate the potential mechanisms through which these products may effect such changes. Such knowledge will contribute to the science base that may inform future policy decisions, and the future grant applications that will be generated from this line of research will ensure that the Candidate experiences a successful transition to becoming an independent researcher. Overall, the research and training activities outlined in this K01 award contribute both to an important area of scientific inquiry, and to the development of a productive and independent research career for the Candidate.
描述(由申请人提供):该K 01奖项有助于实现候选人的长期目标,即为未来有关香烟中尼古丁含量的监管政策提供科学依据,特别是因为该政策影响青少年。本申请中概述的活动为候选人提供了青年吸烟、人类行为药理学和先进统计方法方面的良好培训;候选人建议将这些知识应用于一项创新研究计划,该计划的重点是评估青少年吸烟者中尼古丁含量极低的香烟。将香烟中的尼古丁含量降低到非成瘾水平--这是2009年通过的《家庭吸烟预防和烟草控制法案》(FSPTCA)所实现的一项战略--可以显著降低美国的吸烟率(Benowitz & Henningfield,1994)。这项立法有可能影响一生中的吸烟模式,使香烟对年轻人的强化作用减少,从而减少青少年“瘾君子”的数量,他们将成为终身吸烟者(Sofuoglu和LeSage,2012年)。然而,人们对极低尼古丁含量(VLNC)香烟对青少年的影响知之甚少。尼古丁减少香烟需求的最佳剂量、对吸烟地形的影响、这些香烟的可接受性以及青少年对这些香烟相对风险的看法都是悬而未决的问题。虽然FDA强制降低香烟中的尼古丁含量有可能大幅降低人群的吸烟率,但如果这些吸烟者进行补偿性吸烟或认为VLNC香烟危害较低,则降低香烟中的尼古丁含量可能会对青少年产生意想不到的负面影响。因此,评估青少年吸烟者使用VLNC香烟的积极和消极后果对于评估这一政策的可行性至关重要。我们建议使用两项研究来检查VLNC香烟的影响,一项在实验室完成,另一项在自然环境中完成。在研究1中,我们将比较不同尼古丁含量(正常尼古丁含量,0.83]、降低尼古丁含量[0.28,0.10]和VLNC [0.06] mg产量)的香烟对青少年吸烟者在四个实验室阶段(n=78)中戒断诱导的渴望和戒断、影响、风险感知、产品可接受性和对常用品牌香烟的需求的影响。在研究2中,我们将青少年每日吸烟者(n = 90)随机接受VLNC香烟或正常尼古丁含量(NNC; 0.83 mg)研究香烟,为期三周。参与者将被指示只吸这些香烟。我们将每天对香烟使用总量进行评估(研究香烟及违规使用一般牌子香烟;将密切监测这些每日数据,以获得补偿性吸烟、烟瘾和戒断的证据,每周评估呼吸CO水平、香烟可接受性、VLNC和NNC香烟的风险感知以及对普通品牌香烟的需求,以及尼古丁和毒物暴露(可替宁和NNAL)的使用前与使用后测量。总的来说,该项目将有助于确定VLNC香烟如何影响青少年的真实吸烟行为,并阐明这些产品可能影响这种变化的潜在机制。这些知识将有助于为未来的政策决策提供信息的科学基础,并且从这一研究领域产生的未来拨款申请将确保候选人成功过渡到成为独立研究人员。总的来说,K 01奖项中概述的研究和培训活动有助于以下重要领域: 科学探究,并为候选人发展一个富有成效的和独立的研究生涯。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Initial Development of an E-cigarette Purchase Task: A Mixed Methods Study.
  • DOI:
    10.18001/trs.3.2.2
  • 发表时间:
    2017-04-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Cassidy, Rachel N;Tidey, Jennifer W;Higgins, Stephen T
  • 通讯作者:
    Higgins, Stephen T
Behavioral Economic Research in Addiction as an Area of Growth for the Experimental Analysis of Behavior.
  • DOI:
    10.1037/bar0000105
  • 发表时间:
    2018-11-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Cassidy, Rachel N;Kurti, Allison N
  • 通讯作者:
    Kurti, Allison N
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rachel N Cassidy其他文献

Rachel N Cassidy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rachel N Cassidy', 18)}}的其他基金

Psychometric Validation of an E-Cigarette Purchase Task in Users of Advanced Generation Devices
先进一代设备用户电子烟购买任务的心理测量验证
  • 批准号:
    9128126
  • 财政年份:
    2016
  • 资助金额:
    $ 12.85万
  • 项目类别:
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers
青少年吸烟者尼古丁含量极低香烟的评估
  • 批准号:
    8923221
  • 财政年份:
    2014
  • 资助金额:
    $ 12.85万
  • 项目类别:
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers
青少年吸烟者尼古丁含量极低香烟的评估
  • 批准号:
    9335807
  • 财政年份:
    2014
  • 资助金额:
    $ 12.85万
  • 项目类别:
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers
青少年吸烟者尼古丁含量极低香烟的评估
  • 批准号:
    8746191
  • 财政年份:
    2014
  • 资助金额:
    $ 12.85万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 12.85万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了